عرض بسيط للتسجيلة

المؤلفSharif, E.
المؤلفRizk, N.M.
المؤلفZia, Y.
المؤلفRahman, S.
المؤلفYaser, A.
تاريخ الإتاحة2016-10-10T08:49:43Z
تاريخ النشر2013-05
اسم المنشور2013 Euromedlab Congress 20th IFCC - EFLM European Congress of Clinical Chemistry and Laboratory Medicine
معرّف المصادر الموحدhttp://hdl.handle.net/10576/4857
الملخصPolycystic Ovarian Syndrome is found to be at least 6-10% prevalent all over the world. It is the most common endocrine pathology among females of reproductive age. It is by definition a syndrome having multiple manifestations classically presented by enlarged ovaries with multiple cysts and hypervascularized, androgen secreting stroma. This leads to androgen excess (hirsutism, acne, alopecia), obesity and menstrual irregularity (oligomenorrhoea or amenorrhea). Furthermore women with PCOS have an increased risk of developing several complications like Type 2 diabetes and insulin resistance, cardiovascular disease, obesity, DM and hyperlipideamia 1.
اللغةen
الناشرInternational Federation of Clinical Chemistry and Laboratory Medicine
الموضوعPolycystic Ovary Syndrome (PCOS)
Prevalence
العنوانThe incidence of Polycystic Ovarian Syndrome among Reproductive Females At Qatar University: A Cross-sectional study
النوعConference
dc.accessType Open Access


الملفات في هذه التسجيلة

Thumbnail
Thumbnail

هذه التسجيلة تظهر في المجموعات التالية

عرض بسيط للتسجيلة